Collaborations with SRC Biosciences

SRC Biosciences is situated in the so-called “High Tech I-4 Corridor” that spans 23 central Florida counties from Tampa to Orlando to Gainesville along Interstate 4. The mission of this non-profit organization co-chaired by the Presidents of the University of Central Florida (Orlando), the University of South Florida (Tampa), and the University of Florida (Gainesville) is to grow high-tech industry and innovation through partnerships that support research, marketing, workforce and entrepreneurship.

We play a prominent role in teaching, peer-review and research through several well-established collaborations in the U.S., abroad and Tampa-area. These include Charles University at Prague (Czech Republic), the University of California at San Diego (UCSD), USF Byrd Alzheimer’s Disease Center and the Moffitt Cancer Center. For the past decade, our bioscience experts have served as editors of prominent journals and as standing Study Section members for review of NIH grant proposals.

Funding for Innovative Technology

SRC Biosciences is the only stereology company to receive competitive research funding for technology development (SBIR/STTR grants) from both the National Science Foundation (NSF) and the National Institutes of Health (NIH), as well as other state and national institutions.

Intellectual Property

SRC Biosciences participates in IP-sharing of co-developed technology with USF, one of the nation’s top universities for technology transfer and commercialization.

Publications with Stereologer Data

For more than two decades SRC Biosciences has led the stereology industry with innovative computerized systems (Stereologer®), professional training and efficient study designs for the global bioscience community.
Collaborations 1
From Courchesne, E., Mouton, P.R., Calhoun, M.E., et al., Neuron Number And Size In Prefrontal Cortex Of Children With Autism. Journal Of The American Medical Association (JAMA), 306 (18):2001-10, November 9, 2011.

Peer Reviewed Stereologer Publications (sample of ~60 from over 3,000+ since 1996)